APA

Bueno C., Velasco-Hernandez T., Gutiérrez-Agüera F., Zanetti S. R., Baroni M. L., Sánchez-Martínez D., Molina O., Closa A., Agraz-Doblás A., Marín P., Eyras E., Varela I. & Menéndez P. (20191028). CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. : Leukemia.

Chicago

Bueno Clara, Velasco-Hernandez Talia, Gutiérrez-Agüera Francisco, Zanetti Samanta Romina, Baroni Matteo L, Sánchez-Martínez Diego, Molina Oscar, Closa Adria, Agraz-Doblás Antonio, Marín Pedro, Eyras Eduardo, Varela Ignacio and Menéndez Pablo. 20191028. CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. : Leukemia.

Harvard

Bueno C., Velasco-Hernandez T., Gutiérrez-Agüera F., Zanetti S. R., Baroni M. L., Sánchez-Martínez D., Molina O., Closa A., Agraz-Doblás A., Marín P., Eyras E., Varela I. and Menéndez P. (20191028). CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. : Leukemia.

MLA

Bueno Clara, Velasco-Hernandez Talia, Gutiérrez-Agüera Francisco, Zanetti Samanta Romina, Baroni Matteo L, Sánchez-Martínez Diego, Molina Oscar, Closa Adria, Agraz-Doblás Antonio, Marín Pedro, Eyras Eduardo, Varela Ignacio and Menéndez Pablo. CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity. : Leukemia. 20191028.